Hormone Therapy Offers Potential Protective Effect Against Colon Cancer In Older Women

	Tweet

In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

The study, being presented at the AACR 100th Annual Meeting 2009, was designed to look at possible links between estrogen exposure and colon cancer molecular subtypes, to determine how these hormones might function as anti-cancer agents.

“In our large, prospective study, use of hormone therapy seemed to be beneficial with respect to reducing colorectal cancer risk — women who did use these drugs had a 28 percent lower incidence rate than women who did not use these drugs,” says the study’s lead author, David Limsui, M.D., a fellow in the Department of Gastroenterology at Mayo Clinic’s campus in Rochester, Minn. “But we still don’t know how estrogen compounds work in cancer prevention, which is intriguing.”

Women who reported using other hormone preparations, such as oral contraceptives, did not appear to derive any colorectal cancer prevention benefits. “Based on our findings, we need to continue exploring the cancer pathways that might be affected by these hormones,” Dr. Limsui says.

He adds that other studies have also found that hormone therapy protects postmenopausal women against colon cancer. The largest randomized clinical trial was the 16,000-participant Women’s Health Initiative, which concluded in 2004 that combination hormone therapy (estrogen and progestin) reduced a woman’s risk of colorectal cancer by about 40 percent, he says. “But few studies have delved deeper to see how these hormones work at the molecular level,” Dr. Limsui says.

This investigation is part of the Iowa Women’s Health Study, which enrolled 41,836 women from Iowa, aged 55–69, in 1986. After exclusions, the study group consisted of 37,285 women. In the current study, the investigators examined tumor tissue from 553 colorectal cancer patients, specifically looking for associations between self-reported hormone use and a specific DNA methylation pattern, called the CpG island methylator phenotype, or BRAF gene mutations. No associations were detected between hormone use and these molecular markers. Of note, the investigative team previously reported that certain environmental exposures, such as cigarette smoking, might increase colorectal cancer risk through DNA methylation pathways.

The study was funded by a grant from the National Cancer Institute. Researchers from The University of Iowa, the University of Minnesota, the University of Southern California in Los Angeles, the Masonic Cancer Center in Minneapolis and the Fred Hutchinson Cancer Research Center participated in the research.

About Mayo Clinic
Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of “the needs of the patient come first.” More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Collectively, the three locations treat more than half a million people each year.

For information about research and education, visit http://www.mayo.edu. MayoClinic.com (http://www.mayoclinic.com) is available as a resource for your health stories.

Source: Mayo Clinic

RELATED STORIES:
Can a Mediterranean Diet Help Prevent Colon Cancer?   Fish Oil Protects Against Colon Cancer   Report finds large state disparities in progress against colorectal cancer   Language a Barrier to Colorectal Cancer Screening in Mexican-Americans   Can a Cholesterol Drug Prevent Colon Cancer?   Chinese most prone to colorectal cancer in Asia   Lack of sleep linked to risky colon polyps   City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO   Aspirin Not Effective in Preventing Lynch Syndrome   Hispanics live in areas with limited capacity for colorectal cancer screening   LOH analysis on 4q in sporadic colorectal carcinoma   ‘Cross-talk’ Mechanism Contributes to Colorectal Cancer   Genetic Link Uncovered in Disparate Colon Cancer Death   Virtual colonoscopy an effective colorectal cancer screening exam in Medicare age patientsComputed t   Morning colonoscopy may catch more polyps   Anesthesiologist Treatment Eases Patient Anxiety for Endoscopic Screening Procedures   Protein Levels Indicate Risk of Death in Some Colorectal Cancer Patients   What’s Stopping You? Colorectal Screenings Can Prevent Cancer   Drinking Red Wine Cuts Risk of Colorectal Cancer   Test may find hidden colorectal cancers: study   Curry compound may prevent colon cancer   March is National Colorectal Cancer Awareness Month

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]